5 Einträge gefunden

1. Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial

   1. Jank, Paul
   2. Gehlhaar, Claire
   3. Lederer, Bianca
   4. Fontanella, Caterina
   5. Schneeweiss, Andreas
   6. Karn, Thomas
   7. Marmé, Frederik

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

   1. Sinn, Bruno V
   2. Loibl, Sibylle
   3. Hanusch, Claus A
   4. Zahm, Dirk-Michael
   5. Sinn, Hans-Peter
   6. Untch, Michael
   7. Weber, Karsten

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial

   1. Jank, Paul
   2. Gehlhaar, Claire
   3. Bianca, Lederer
   4. Caterina, Fontanella
   5. Andreas, Schneeweiss
   6. Karn, Thomas
   7. Marmé, Frederik

   2020 - Forschungsinformationssystem des UKE
4. Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer

   1. Thewes, Verena
   2. Simon, Ronald
   3. Schroeter, Petra
   4. Schlotter, Magdalena
   5. Anzeneder, Tobias
   6. Büttner, Reinhard
   7. Benes, Vladimir

   2015 - Forschungsinformationssystem des UKE
5. Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort - Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake

   1. Seibold, Petra
   2. Vrieling, Alina
   3. Heinz, Judith
   4. Obi-Osius, Nadia
   5. Sinn, Hans-Peter
   6. Flesch-Janys, Dieter
   7. Chang-Claude, Jenny

   2014 - Forschungsinformationssystem des UKE